1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Gastrointestinal Stents Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product Type
6.1 Biliary Stents
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Duodenal Stents
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Colonic Stents
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Pancreatic Stents
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Esophageal Stents
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Technology Type
7.1 Anti-Migratory Stents
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Drug-Eluting Stents
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Radioactive Stents
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Anti-Reflux Stents
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Shape-Modified Stents
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Material
8.1 Plastic Stents
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Self-Expanding Metal Stents
8.2.1 Market Trends
8.2.2 Major Types
8.2.2.1 Stainless Steel Stents
8.2.2.2 Nitinol Stents
8.2.2.3 Others
8.2.3 Market Forecast
8.3 Covered Self-Expandable Metallic Stents
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Biodegradable or Drug Eluting Stents
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Specialty Clinics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Ambulatory Surgical Centres
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Indicators
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Becton, Dickinson and Company
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Boston Scientific Corporation
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Cantel Medical Corporation
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Conmed Corporation
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Cook Group Incorporated
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 ELLA-CS, S.R.O.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Hobbs Medical Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Merit Medical Systems Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Olympus Corporation
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Taewoong Medical Co, Ltd.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer